by Marie Daghlian | Jan 19, 2020 | Analysis, M&A
Analysis | M&A Life Sciences M&A Tops $240 Billion in 2019 This article is a sample from the DealForma Annual Deal Trends Report provided to database subscribers. Data for this analysis was compiled using the DealForma biopharma deals database. We applied...
by Marie Daghlian | Apr 23, 2019 | Analysis, Partnership Deals
Analysis | Partnership Deals Biopharma Partnering Sets Records in Q1 2019 after a Strong 2018 This article is a sample from the DealForma Quarterly Deal Trends Report provided to database subscribers. Data for this analysis was compiled using the DealForma biopharma...
by Marie Daghlian | Jan 4, 2019 | Analysis, M&A
Analysis | M&A Life Sciences M&A Starts with a Bang in 2019 after Rebounding in 2018 Data for the this analysis was compiled using the DealForma database on deals. We applied initial filters for mergers and acquisitions, target company types, therapeutic...
by Marie Daghlian | Dec 10, 2018 | Analysis, Partnership Deals
Analysis | Partnership Deals Oncology Partnering Deal Trends: Early Stage Deals Dominate with Highest Potential Deal Values Data for the this analysis was compiled using the DealForma database on deals. We applied initial filters for deal types, therapeutic areas,...
by Marie Daghlian | Nov 27, 2018 | Analysis, Funding
Analysis | Funding Top Investors in Biotech Venture Rounds Data for the this analysis was compiled using the DealForma database; specifically the companies and venture funding sections. We used company location data tagged with the three major U.S. biotech hubs along...
by Marie Daghlian | Nov 10, 2018 | Analysis, Funding
Analysis | Funding Biotech Companies in Major Industry Centers Rake in the Cash Data for the this analysis was compiled using the DealForma database; specifically the companies and venture funding sections. We used company location data tagged with the three major...
